TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 14
1.1.1 GLOBAL TRIFLUOROACETIC ACID MARKET, BY TYPE 16
1.1.2 GLOBAL TRIFLUOROACETIC ACID MARKET, BY APPLICATION 17
1.1.3 GLOBAL TRIFLUOROACETIC ACID MARKET, BY REGION 18
2 MARKET INTRODUCTION 19
2.1 DEFINITION 19
2.2 SCOPE OF THE STUDY 19
2.3 MARKET STRUCTURE 19
3 RESEARCH METHODOLOGY 20
3.1 RESEARCH PROCESS 20
3.2 PRIMARY RESEARCH 21
3.3 SECONDARY RESEARCH 22
3.4 MARKET SIZE ESTIMATION 22
3.5 FORECAST MODEL 24
3.6 LIST OF ASSUMPTIONS 24
4 MARKET DYNAMICS 25
4.1 INTRODUCTION 25
4.2 DRIVERS 26
4.2.1 HIGH DEMAND FROM THE PHARMACEUTICAL INDUSTRY 26
4.2.2 GROWTH OF THE AGRICULTURE INDUSTRY 27
4.2.3 DRIVERS IMPACT ANALYSIS 28
4.3 RESTRAINTS 28
4.3.1 TOXIC NATURE AND ENVIRONMENTAL CONCERNS 28
4.3.2 RESTRAINTS IMPACT ANALYSIS 29
4.4 OPPORTUNITIES 29
4.4.1 POSITIVE OUTLOOK OF THE PHARMACEUTICAL INDUSTRY IN SOUTH ASIA 29
4.5 CHALLENGES 30
4.5.1 AVAILABILITY OF SUBSTITUTES 30
5 MARKET FACTOR ANALYSIS 31
5.1 SUPPLY CHAIN ANALYSIS 31
5.1.1 RAW MATERIALS SUPPLIERS 32
5.1.2 TRIFLUOROACETIC ACID MANUFACTURERS 32
5.1.3 DISTRIBUTION CHANNEL 32
5.1.4 APPLICATIONS 32
5.2 PORTER’S FIVE FORCES MODEL 33
5.2.1 THREAT OF NEW ENTRANTS 33
5.2.2 BARGAINING POWER OF SUPPLIERS 33
5.2.3 THREAT OF SUBSTITUTES 34
5.2.4 BARGAINING POWER OF BUYERS 34
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 34
5.3 PRICING ANALYSIS, BY REGION 34
5.4 IMPACT OF COVID-19 ON THE GLOBAL TRIFLUOROACETIC ACID MARKET 34
5.4.1 PRODUCTION SCENARIO 34
5.4.2 IMPACT ON SUPPLY CHAIN 35
5.4.2.1 RAW MATERIAL SUPPLY 35
5.4.2.2 SUPPLY/ DISTRIBUTION 35
5.4.2.3 IMPACT ON END USE INDUSTRY DEMAND 35
5.4.3 MAJOR GOVERNMENT POLICIES TO COUNTER THE IMPACT OF COVID-19 36
6 GLOBAL TRIFLUOROACETIC ACID (TFA) MARKET, BY TYPE 39
6.1 OVERVIEW 39
6.1.1 TRIFLUOROACETIC ACID (TFA): MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030 40
6.1.2 TRIFLUOROACETIC ACID (TFA): MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030 40
6.2 ABOVE 99.5% TRIFLUOROACETIC ACID 41
6.2.1 ABOVE 99.5% TRIFLUOROACETIC ACID: MARKET ESTIMATES & FORECAST BY REGION, 2019-2030 41
6.3 OTHERS 42
6.3.1 OTHERS: MARKET ESTIMATES & FORECAST BY REGION, 2019-2030 42
7 GLOBAL TRIFLUOROACETIC ACID (TFA) MARKET, BY APPLICATION 43
7.1 OVERVIEW 43
7.1.1 TRIFLUOROACETIC ACID (TFA): MARKET ESTIMATES & FORECAST BY APPLICATION, 2019-2030 44
7.1.2 TRIFLUOROACETIC ACID (TFA): MARKET ESTIMATES & FORECAST BY APPLICATION, 2019-2030 45
7.2 MEDICAL INTERMEDIATES 45
7.2.1 MEDICAL INTERMEDIATES: MARKET ESTIMATES & FORECAST BY REGION, 2019-2030 45
7.3 PESTICIDE INTERMEDIATES 46
7.3.1 PESTICIDE INTERMEDIATES: MARKET ESTIMATES & FORECAST BY REGION, 2019-2030 46
7.4 OTHERS 47
7.4.1 OTHERS: MARKET ESTIMATES & FORECAST BY REGION, 2019-2030 47
8 GLOBAL TRIFLUOROACETIC ACID (TFA) MARKET, BY REGION 49
8.1 OVERVIEW 49
8.2 NORTH AMERICA 52
8.2.1 US 54
8.2.2 CANADA 55
8.3 EUROPE 57
8.3.1 GERMANY 59
8.3.2 UK 61
8.3.3 FRANCE 62
8.3.4 SPAIN 63
8.3.5 ITALY 65
8.3.6 RUSSIA 66
8.3.7 REST OF EUROPE 67
8.4 ASIA-PACIFIC 69
8.4.1 CHINA 71
8.4.2 JAPAN 73
8.4.3 INDIA 74
8.4.4 SOUTH KOREA 75
8.4.5 AUSTRALIA & NEW ZEALAND 77
8.4.6 REST OF ASIA-PACIFIC 78
8.5 LATIN AMERICA 80
8.5.1 BRAZIL 82
8.5.2 MEXICO 83
8.5.3 ARGENTINA 84
8.5.4 REST OF LATIN AMERICA 86
8.6 THE MIDDLE EAST & AFRICA 88
8.6.1 GCC 90
8.6.2 ISRAEL 92
8.6.3 SOUTH AFRICA 93
8.6.4 REST OF THE MIDDLE EAST & AFRICA 94
9 COMPETITIVE LANDSCAPE 96
9.1 INTRODUCTION 96
9.2 MARKET STRATEGY ANALYSIS 96
9.3 COMPETITIVE BENCHMARKING 97
10 COMPANY PROFILES 98
10.1 SOLVAY 98
10.1.1 COMPANY OVERVIEW 98
10.1.2 FINANCIAL OVERVIEW 98
10.1.3 PRODUCTS OFFERED 99
10.1.4 KEY DEVELOPMENTS 99
10.1.5 SWOT ANALYSIS 99
10.1.6 KEY STRATEGIES 100
10.2 SRF LIMITED 101
10.2.1 COMPANY OVERVIEW 101
10.2.2 FINANCIAL OVERVIEW 101
10.2.3 PRODUCTS OFFERED 102
10.2.4 KEY DEVELOPMENTS 102
10.2.5 SWOT ANALYSIS 102
10.2.6 KEY STRATEGIES 102
10.3 HALOCARBON LLC 103
10.3.1 COMPANY OVERVIEW 103
10.3.2 FINANCIAL OVERVIEW 103
10.3.3 PRODUCTS OFFERED 103
10.3.4 KEY DEVELOPMENT 103
10.3.5 SWOT ANALYSIS 104
10.3.6 KEY STRATEGIES 104
10.4 SINOCHEM GROUP CO., LTD 105
10.4.1 COMPANY OVERVIEW 105
10.4.2 FINANCIAL OVERVIEW 105
10.4.3 PRODUCTS OFFERED 106
10.4.4 KEY DEVELOPMENTS 106
10.4.5 SWOT ANALYSIS 106
10.4.6 KEY STRATEGIES 106
10.5 ANHUI JIN’AO CHEMICAL CO., LTD 107
10.5.1 COMPANY OVERVIEW 107
10.5.2 FINANCIAL OVERVIEW 107
10.5.3 PRODUCTS OFFERED 107
10.5.4 KEY DEVELOPMENTS 107
10.5.5 SWOT ANALYSIS 108
10.5.6 KEY STRATEGIES 108
10.6 NANTONG BAOKAI PHARMACEUTICAL CO., LTD 109
10.6.1 COMPANY OVERVIEW 109
10.6.2 FINANCIAL OVERVIEW 109
10.6.3 PRODUCTS OFFERED 109
10.6.4 KEY DEVELOPMENTS 109
10.6.5 SWOT ANALYSIS 110
10.6.6 KEY STRATEGIES 110
10.7 MIDAS PHARMA GMBH 111
10.7.1 COMPANY OVERVIEW 111
10.7.2 FINANCIAL OVERVIEW 111
10.7.3 PRODUCTS OFFERED 111
10.7.4 KEY DEVELOPMENTS 111
10.7.5 SWOT ANALYSIS 112
10.7.6 KEY STRATEGIES 112
11 APPENDIX 113
11.1 REFERENCES 113
11.2 RELATED REPORTS 113
